What is lyndra therapeutics weekly risperidone? July 19, 2021 - Lyndra Therapeutics Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for Lyndra’s Weekly Risperidone (LYN-005) for the Treatment of Adults with Schizophrenia and Other Indications Currently, medication non-adherence costs more and affects more people than any single disease.What is lyndras goal? The aim is to improve medication adherence, health outcomes, and help lower the cost of care. Lyndra’s near-term focus is on addressing health conditions where therapeutic need is largely unmet and where patient non-adherence has been well documented to adversely affect health outcomes.What is lyndras dosage form? The video provides an overview of the dosage form. Lyndra’s dosage form is a normal capsule containing a drug containing element with components specifically designed to perform certain functions during oral administration, gastric residence and lower GI passage.Who was the first ceo of hydra biosciences? Prior to Millennium, Laurie was co-founder and the first CEO of Hydra Biosciences, Inc. Before co-founding Hydra, she served as an executive at high-growth technology companies, including Iomega Corporation, and Sybase, Inc., a software company that grew from a few hundred to 6,000 employees during Laurie’s tenure on the management team.
Lyndra Therapeutics has 5 board members and advisors, including Giovanni Traverso. Giovanni Traverso Board Member 2015. Catherine B. Reynolds Board Member 2016. Amy Schulman Board Member 2015. Zafrira Avnur Board Member 2016.